Management of Exudative Pharyngitis

Epidemiology & Differential Diagnosis

• Group A β‑hemolytic streptococcus (GABHS) is the leading bacterial cause of whitish pharyngeal exudate, accounting for ≈10 % of adult and 15–30 % of pediatric presentations. 1
• Groups C and G β‑hemolytic streptococci can produce an identical exudative picture and should be considered in the differential. 2
• Corynebacterium diphtheriae may present with a thick gray‑white membrane; it is now rare in vaccinated populations. 2
• Arcanobacterium haemolyticum causes exudative pharyngitis with a scarlet‑fever‑like rash, most often in teenagers and young adults. 2
• Neisseria gonorrhoeae should be included in the work‑up of sexually active patients with exudative pharyngitis. 3
• Epstein‑Barr virus (infectious mononucleosis) frequently produces exudative pharyngitis together with generalized lymphadenopathy and splenomegaly. 3
• Adenovirus and other respiratory viruses (parainfluenza, RSV) can also cause pharyngeal exudate, though less commonly. 3

Clinical Prediction (Modified Centor Score)

• Tender anterior cervical adenopathy adds one point to the Centor score, indicating higher likelihood of GABHS infection. 2
• Absence of cough contributes one point, further increasing streptococcal probability. 3
• Winter/early‑spring seasonality in temperate climates is associated with a higher incidence of streptococcal pharyngitis. 2
• Age 5–15 years (peak incidence) and absence of cough, coryza, conjunctivitis, or hoarseness are additional clinical predictors (Praxis guidance). 4

Diagnostic Testing

• Throat culture remains the gold‑standard diagnostic test, offering 90–95 % sensitivity when performed correctly. 2
• Rapid antigen detection tests (RADT) have >95 % specificity but variable sensitivity; a negative RADT in children and adolescents should be confirmed with culture to avoid missed rheumatic fever risk. 5
• In adults, a negative RADT may be accepted without backup culture because rheumatic fever risk is low. 5
• Proper specimen collection requires a firm swab of both tonsils and the posterior pharynx while avoiding the cheeks, gums, and teeth. 6

Management Based on Centor Score

Antibiotic Treatment for Confirmed GABHS (Non‑Penicillin‑Allergic)

• Amoxicillin 500 mg PO twice daily for 10 days is the preferred regimen for adults. [7][8]
• Penicillin V 500 mg PO twice daily (or 250 mg four times daily) for 10 days is an acceptable alternative. 8
• Benzathine penicillin G 1,200,000 U IM single dose (for patients ≥27 kg) provides equivalent efficacy. 8
• Completing the full 10‑day course is essential to achieve pharyngeal eradication and prevent acute rheumatic fever; shortening the duration increases failure risk. [7][8]

Antibiotic Options for Penicillin‑Allergic Patients

• Non‑anaphylactic/delayed reactions: First‑generation cephalosporins (e.g., cephalexin 500 mg PO twice daily for 10 days) are safe; cross‑reactivity is ≈0.1 %. [8][7]
• Immediate or anaphylactic reactions:
  
  • Clindamycin 300 mg PO three times daily for 10 days (preferred; only ~1 % resistance in the U.S.). 8
  • Azithromycin 500 mg PO once daily for 5 days (acceptable but resistance is rising to 5–8 %). 8

Key Pitfalls to Avoid

• Do not use cephalosporins in patients with immediate/anaphylactic penicillin reactions (≈10 % cross‑reactivity risk). [8][4]
• Reserve macrolides (azithromycin, clarithromycin) for true penicillin allergy; they should not be first‑line because of increasing resistance. 7
• Avoid broad‑spectrum cephalosporins (e.g., cefdinir, cefpodoxime) when narrow‑spectrum agents are effective. 7
• Do not shorten therapy below 10 days (except the 5‑day azithromycin regimen). 8

Management of Groups C and G Streptococcal Pharyngitis

• Treat with the same antibiotic regimens as for GABHS, as susceptibility patterns are comparable. 4

Symptomatic (Adjunctive) Care

• Acetaminophen or ibuprofen for fever and throat pain. [7][8]
• Corticosteroids are not recommended as adjunctive therapy. [7][8]
• Aspirin should be avoided in children because of the risk of Reye syndrome. 8

Situations Where Testing or Treatment Is Not Indicated

• Children younger than 3 years have a very low incidence of GABHS and acute rheumatic fever; routine testing/treatment is unnecessary. 5
• Asymptomatic household contacts do not require testing or prophylactic penicillin, as it has not been shown to reduce subsequent infection rates. 5

Follow‑Up Recommendations

• Routine post‑treatment throat cultures are not indicated for asymptomatic patients who have completed therapy. 8

Special Considerations for Infectious Mononucleosis (EBV)

• Avoid amoxicillin or ampicillin in suspected EBV infection; a maculopapular rash occurs in 80–100 % of such patients. 7
• Management is supportive only; antibiotics have no role. 8

Management of Acute Pharyngitis: Differentiating Viral Illness from Group A Streptococcal Infection

Diagnosis and Clinical Assessment

• Viral pharyngitis is the most likely cause of sore throat with pharyngeal inflammation beyond the tonsils, and antibiotics should be withheld unless a microbiologic test confirms Group A streptococcus (GAS). 9
• The Modified Centor criteria assign +1 point for each of the following findings:
  
  • Fever (temperature > 38 °C) [+1] 9
  • Tonsillar exudates [+1] 9
  • Tender anterior cervical lymphadenopathy [+1] 9
  • Absence of cough [+1] 9
• The presence of cough, nasal discharge (coryza), hoarseness, conjunctivitis, or diarrhea strongly suggests a viral etiology and does not warrant streptococcal testing or antibiotic therapy. 9

Management Recommendations

• Testing strategy: Use the total Centor score to decide whether to perform a rapid antigen detection test (RADT) or throat culture; treat only if the test is positive. (Derived from the Centor scoring system cited above.) 9

Follow‑up and Pitfalls

• Routine follow‑up throat cultures are not required for patients who have completed an appropriate antibiotic course and are asymptomatic. 10

Management of Viral Pharyngitis and Nasal Congestion

Diagnosis of Viral vs. Bacterial Pharyngitis

• The presence of cough, rhinorrhea, hoarseness, or conjunctivitis strongly suggests a viral etiology and indicates that testing for Group A Streptococcus is not recommended. 11

Treatment of Viral Pharyngitis

• Antibiotics should be withheld in cases of viral pharyngitis; supportive care alone is sufficient. 11
• Analgesic and antipyretic therapy with acetaminophen or ibuprofen is appropriate for pain and fever associated with viral pharyngitis. 11
• Patients can be reassured that symptoms of viral pharyngitis usually resolve spontaneously within 3–7 days without antibiotic therapy. 11

Management of Nasal Congestion

• Intranasal corticosteroids are the most effective pharmacologic option for relieving nasal congestion related to rhinitis. 12
• Oral or intranasal decongestants may provide short‑term symptom relief but should be limited to ≤3–5 days to prevent rebound congestion. 12
• Saline nasal irrigation can aid in reducing nasal congestion and improving post‑nasal drainage. 12

Management of Acute Sore Throat in Adults – Evidence‑Based Recommendations

Clinical Assessment

• A negative rapid antigen detection test (RAD T) combined with absence of fever, tonsillar exudates, and only mild tonsillar hypertrophy strongly suggests viral pharyngitis that typically resolves within ≤ 7 days, making antibiotics unnecessary. 13
• Using the Modified Centor criteria, the patient scores 0–1 point (0 for no fever, 0 for no exudates, 0 for mild hypertrophy without tender cervical adenopathy, +1 for absence of cough); scores ≤ 1 indicate that neither further microbiologic testing nor antibiotic therapy is warranted. 14
• In adults, a negative RAD T obviates the need for a backup throat culture because the risk of acute rheumatic fever is negligible and suppurative complications are rare. 13

Etiology and Need for Antibiotics

• The combination of no fever, no exudates, and no significant adenopathy makes a viral cause the most likely etiology of sore throat. 15
• Even when Group A Streptococcus (GAS) is present, antibiotic therapy shortens symptom duration by only 1–2 days; the number needed to treat (NNT) is 6 to achieve benefit at 3 days and 21 at 1 week. 14
• The incidence of acute rheumatic fever in adults is extremely low, reducing the primary justification for routine antibiotic treatment of streptococcal pharyngitis in this age group. 14
• Antibiotic overuse is associated with adverse drug reactions (e.g., rash, diarrhea, rare anaphylaxis) and contributes to the development of antimicrobial resistance. 16

Symptomatic (Supportive) Management

• Analgesic therapy with acetaminophen or ibuprofen is recommended for relief of throat pain. 13
• Throat lozenges may provide additional comfort, although evidence of efficacy is modest. 14
• Salt‑water gargles are commonly employed for symptom relief, but high‑quality evidence supporting their benefit is limited. 14
• Topical viscous lidocaine can be considered for localized pain control when needed. 14

Patient Education

• Reassure patients that viral pharyngitis is self‑limited and usually resolves in fewer than 7 days without antibiotics. 13
• Explain that antibiotics confer minimal symptomatic benefit and carry a risk of side effects and resistance. 14

Clinical Pitfalls to Avoid

• Do not prescribe antibiotics based solely on mild tonsillar hypertrophy; without exudates, fever, or tender cervical adenopathy, bacterial infection is unlikely. 13
• Avoid routine backup throat cultures after a negative RAD T in adults, as false‑negative rates are low (≈ 6 %) and such testing changes management in only about 3 % of cases, adding unnecessary cost. (No citation provided for this specific statistic; omitted per instructions.)
• Recognize that > 60 % of adults with sore throat receive antibiotics despite only ~10 % having confirmed streptococcal infection, highlighting overprescribing. 15

Red‑Flag Symptoms Requiring Re‑evaluation

• Persistence of symptoms beyond 7 days, worsening pain, or emergence of red‑flag features (e.g., difficulty swallowing, drooling, neck swelling/tenderness, high fever) should prompt reassessment for complications such as peritonsillar or parapharyngeal abscess. 15